anti phospho her2 erbb2 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
anti phospho her2 erbb2
Anti Phospho Her2 Erbb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 312 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/her2+rabbit+mab/Phospho-HER2%2FErbB2+(Tyr1221%2F1222)+Rabbit+mAb/pmc13041752-3-0-3
Average 96 stars, based on 312 article reviews
Anti Phospho Her2 Erbb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 312 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/her2+rabbit+mab/Phospho-HER2%2FErbB2+(Tyr1221%2F1222)+Rabbit+mAb/pmc13041752-3-0-3
Average 96 stars, based on 312 article reviews
anti phospho her2 erbb2 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Incubation:Article Title: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer. Article Snippet: .. After being treated with pyrotinib and lapatinib, the cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and incubated with a blocking solution and Article Title: New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer. Article Snippet: Electrophoresis was performed at 80 V for 15 min and then at 130 V for 60 min, followed by transfer to a PVDF membrane using the iBlot3 Dry Blotting System (Thermo Fisher Scientific, Waltham, MA, USA). .. Nonspecific binding sites were blocked with 5% BSA for 1 h at room temperature, followed by for 18 h incubation at 4 °C with primary antibodies against Hsp90 Rabbit mAb (1:1000), Hsp70 Mouse mAb (1:1000), cRAF Rabbit mAb (1:1000), GAPDH Rabbit mAb (1:2500), AKT Rabbit mAb (1:1000), phospho-AKT rabbit mAb (1:1000), phospho-MEK rabbit mAb (1:1000), MEK rabbit mAb (1:1000), phospho-ERK mouse mAb (1:1000), ERK mouse mAb (1:1000), CDK4 rabbit mAb (1:1000), ERα rabbit mAb (1:1000), Article Title: New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer Article Snippet: Electrophoresis was performed at 80 V for 15 min and then at 130 V for 60 min, followed by transfer to a PVDF membrane using the iBlot3 Dry Blotting System (Thermo Fisher Scientific, Waltham, MA, USA). .. Nonspecific binding sites were blocked with 5% BSA for 1 h at room temperature, followed by for 18 h incubation at 4 °C with primary antibodies against Hsp90 Rabbit mAb (1:1000), Hsp70 Mouse mAb (1:1000), cRAF Rabbit mAb (1:1000), GAPDH Rabbit mAb (1:2500), AKT Rabbit mAb (1:1000), phospho-AKT rabbit mAb (1:1000), phospho-MEK rabbit mAb (1:1000), MEK rabbit mAb (1:1000), phospho-ERK mouse mAb (1:1000), ERK mouse mAb (1:1000), CDK4 rabbit mAb (1:1000), ERα rabbit mAb (1:1000), Article Title: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer Article Snippet: .. After being treated with pyrotinib and lapatinib, the cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and incubated with a blocking solution and Blocking Assay:Article Title: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer. Article Snippet: .. After being treated with pyrotinib and lapatinib, the cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and incubated with a blocking solution and Article Title: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer Article Snippet: .. After being treated with pyrotinib and lapatinib, the cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and incubated with a blocking solution and Binding Assay:Article Title: New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer. Article Snippet: Electrophoresis was performed at 80 V for 15 min and then at 130 V for 60 min, followed by transfer to a PVDF membrane using the iBlot3 Dry Blotting System (Thermo Fisher Scientific, Waltham, MA, USA). .. Nonspecific binding sites were blocked with 5% BSA for 1 h at room temperature, followed by for 18 h incubation at 4 °C with primary antibodies against Hsp90 Rabbit mAb (1:1000), Hsp70 Mouse mAb (1:1000), cRAF Rabbit mAb (1:1000), GAPDH Rabbit mAb (1:2500), AKT Rabbit mAb (1:1000), phospho-AKT rabbit mAb (1:1000), phospho-MEK rabbit mAb (1:1000), MEK rabbit mAb (1:1000), phospho-ERK mouse mAb (1:1000), ERK mouse mAb (1:1000), CDK4 rabbit mAb (1:1000), ERα rabbit mAb (1:1000), Article Title: New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer Article Snippet: Electrophoresis was performed at 80 V for 15 min and then at 130 V for 60 min, followed by transfer to a PVDF membrane using the iBlot3 Dry Blotting System (Thermo Fisher Scientific, Waltham, MA, USA). .. Nonspecific binding sites were blocked with 5% BSA for 1 h at room temperature, followed by for 18 h incubation at 4 °C with primary antibodies against Hsp90 Rabbit mAb (1:1000), Hsp70 Mouse mAb (1:1000), cRAF Rabbit mAb (1:1000), GAPDH Rabbit mAb (1:2500), AKT Rabbit mAb (1:1000), phospho-AKT rabbit mAb (1:1000), phospho-MEK rabbit mAb (1:1000), MEK rabbit mAb (1:1000), phospho-ERK mouse mAb (1:1000), ERK mouse mAb (1:1000), CDK4 rabbit mAb (1:1000), ERα rabbit mAb (1:1000), other:Article Title: Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models Article Snippet: |
